​

Alignment Healthcare (ALHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ALHC Stock Forecast

Alignment Healthcare (ALHC) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $19.75, with a high of $22.00 and a low of $18.00. This represents a 1.75% increase from the last price of $19.41.

- $5 $10 $15 $20 $25 High: $22 Avg: $19.75 Low: $18 Last Closed Price: $19.41

ALHC Stock Rating

Alignment Healthcare stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 1 Strong Buy (6.25%), 13 Buy (81.25%), 2 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 2 13 1 Strong Sell Sell Hold Buy Strong Buy

ALHC Price Target Upside V Benchmarks

TypeNameUpside
StockAlignment Healthcare1.75%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks14.06%

Price Target Trends

1M3M12M
# Anlaysts-47
Avg Price Target-$19.75$18.57
Last Closing Price$19.41$19.41$19.41
Upside/Downside-1.75%-4.33%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25292--13
Nov, 25193--13
Oct, 25183--12
Sep, 25183--12
Aug, 25174--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 03, 2025Scott FidelGoldman Sachs$22.00$16.8630.49%13.34%
Oct 31, 2025Barclays$18.00$16.886.64%-7.26%
Oct 31, 2025Kevin CaliendoUBS$18.00$18.53-2.86%-7.26%
Oct 14, 2025Goldman Sachs$21.00$17.3121.32%8.19%
Aug 25, 2025Matthew GillmorKeyBanc$21.00$15.5834.79%8.19%
Mar 04, 2025Piper Sandler$21.00$15.7533.33%8.19%
Aug 14, 2024Michael HaRobert W. Baird$11.00$8.4929.56%-43.33%
Aug 05, 2024Andrew MokBarclays$7.00$8.94-21.70%-63.94%
Jul 26, 2024Craig JonesStifel Nicolaus$12.00$9.3628.21%-38.18%
May 08, 2024Jessica TassanPiper Sandler$8.00$6.7817.99%-58.78%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 24, 2025KeyBancOverweightOverweighthold
Nov 03, 2025Goldman SachsBuyBuyhold
Oct 31, 2025UBSNeutralNeutralhold
Oct 14, 2025Goldman SachsBuyinitialise
Aug 25, 2025KeyBancSector WeightOverweightupgrade
Mar 04, 2025Piper SandlerOverweightOverweighthold
Oct 31, 2024Cowen & Co.BuyBuyhold
Oct 30, 2024BarclaysUnderweightUnderweighthold
Oct 10, 2024KeyBancSector Weightinitialise
Aug 06, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.24$-0.83$-0.79$-0.67----
Avg Forecast$-1.00$-0.70$-0.66$-0.68$-0.53$-0.39$-0.18$0.74
High Forecast$-0.97$-0.67$-0.63$-0.64$-0.27$-0.10$0.29$0.79
Low Forecast$-1.05$-0.74$-0.67$-0.73$-0.65$-0.62$-0.54$0.70
Surprise %24.00%18.57%19.70%-1.47%----

Revenue Forecast

$1B $2B $3B $5B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.17B$1.43B$1.82B$2.70B----
Avg Forecast$1.14B$1.41B$1.80B$2.68B$3.48B$4.29B$5.17B$6.24B
High Forecast$1.18B$1.47B$1.82B$2.69B$3.60B$4.29B$5.42B$6.55B
Low Forecast$1.12B$1.36B$1.79B$2.67B$3.32B$4.29B$4.97B$6.00B
Surprise %2.42%1.49%1.20%0.98%----

Net Income Forecast

$-250M $-170M $-90M $-10M $70M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-212.96M$-149.64M$-148.02M$-128.03M----
Avg Forecast$-186.80M$-130.50M$-121.43M$-127.52M$-95.41M$-79.65M$-35.38M$137.80M
High Forecast$-181.47M$-124.51M$-117.46M$-120.02M$-50.86M$-19.52M$54.00M$146.54M
Low Forecast$-195.97M$-137.66M$-125.40M$-135.02M$-120.79M$-115.15M$-100.56M$130.97M
Surprise %14.01%14.67%21.89%0.40%----

ALHC Forecast FAQ

Is Alignment Healthcare stock a buy?

Alignment Healthcare stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 13 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alignment Healthcare is a favorable investment for most analysts.

What is Alignment Healthcare's price target?

Alignment Healthcare's price target, set by 16 Wall Street analysts, averages $19.75 over the next 12 months. The price target range spans from $18 at the low end to $22 at the high end, suggesting a potential 1.75% change from the previous closing price of $19.41.

How does Alignment Healthcare stock forecast compare to its benchmarks?

Alignment Healthcare's stock forecast shows a 1.75% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare plans stocks industry (14.06%).

What is the breakdown of analyst ratings for Alignment Healthcare over the past three months?

  • December 2025: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 7.69% Strong Buy, 69.23% Buy, 23.08% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Alignment Healthcare’s EPS forecast?

Alignment Healthcare's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.53, marking a -20.90% decrease from the reported $-0.67 in 2024. Estimates for the following years are $-0.39 in 2026, $-0.18 in 2027, and $0.74 in 2028.

What is Alignment Healthcare’s revenue forecast?

Alignment Healthcare's average annual revenue forecast for its fiscal year ending in December 2025 is $3.48B, reflecting a 28.76% increase from the reported $2.7B in 2024. The forecast for 2026 is $4.29B, followed by $5.17B for 2027, and $6.24B for 2028.

What is Alignment Healthcare’s net income forecast?

Alignment Healthcare's net income forecast for the fiscal year ending in December 2025 stands at $-95.41M, representing a -25.48% decrease from the reported $-128M in 2024. Projections indicate $-79.649M in 2026, $-35.38M in 2027, and $137.8M in 2028.